Global Cat Allergy Therapeutics Market: Overview

Cat allergy is an allergic reaction in humans to the allergens produced by cats. The most common cat allergen types are Fel d1 (secreted by cat’s sebaceous glands) and Fel d4 (found in cat’s saliva). Nearly 25% of allergic patients tend to suffer from cat allergy due to Fel d1 and Fel d4. Cat allergens are produced in large amounts, especially Fel d1, in the form of dander and is considered to be a major reason of causing allergic asthma across the world. Avoiding cats is the primary therapy for allergic patients. However, certain allergy drugs and allergy shots help to control the symptoms of cat allergy.

Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62190

Global Cat Allergy Therapeutics Market: Key Trends

Increase in the number of patients with cat allergy, rise in the trend of having cat as pet animal, and surge in awareness about available treatment options are projected to drive the global cat allergy therapeutics market during the forecast period. Moreover, rise in cases of allergic rhinitis and allergic asthma due to cat allergy are anticipated to augment the global market. Increase in health care expenditure by governments and initiatives to spread awareness about the treatment are also expected to propel the global cat allergy therapeutics market. Increase in investment in research & development especially in immunotherapy treatment is likely to boost the growth of the global cat allergy therapeutics market. For instance, as per journal published by AAIR (Allergy, Asthma Immunology Research), in 2018, expenditure on allergic rhinitis is estimated at EUR 2.7 Bn per year. It is the most expensive disease in the U.S., costing around US$ 593 per employee/year. Moreover, increase in the sensitized population across the world and rise in ownership of domestic animals are anticipated to propel the global cat allergy therapeutics market during the forecast period. However, unmet needs in the diagnosis and treatment of animal (cat) allergies, inappropriate medical management, and stringent guidelines are likely to restrain the global cat allergy therapeutics market during the forecast period.

Request COVID Analysis on Cat Allergy Therapeutics Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=62190

Global Cat Allergy Therapeutics Market: Segmentation

The global cat allergy therapeutics market can be segmented based of treatment, route of administration, end-user, and region. In terms of treatment, the market can be classified into antihistamines, decongestants, corticosteroids, immunotherapy, and others. Antihistamine includes cetirizine, diphenhydramine, and fexofenadine. Based on route of administration, the global cat allergy therapeutics market can be categorized into oral, nasal, and subcutaneous. In terms of distribution channel, the market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.

Global Cat Allergy Therapeutics Market: Geographical Distribution

In terms of region, the global cat allergy therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017 and the trend is projected to continue during the forecast period. This is attributed to rise in prevalence of cat allergies in people, increase in awareness about cat allergy symptoms, surge in health care expenditure, and rise in demand for diagnostic kits used to detect cat allergy. According to the American Pet Products Association, in 2017, there are 85.8 million pet cats worldwide; and in the U.S. there were 42.9 million cats (35% households happen to have these pet cats). Rise in prevalence of allergic diseases such as allergic rhinoconjunctivitis and allergic asthma due to cat allergy is anticipated to augment the global cat allergy therapeutics market. The market in Europe and Asia Pacific is expected to grow at a rapid pace during the forecast period. Increasing sensitization due to the allergen of the domestic animals are likely to drive the market in these regions during the forecast period. For instance, sensitization in cats is 12.2% and 30.8% to cat hair in China. Sensitization to cat hair is 8.1% in developing regions and 8.7% in the developed regions. According to a journal published by Allergy, Asthma & Immunology Research (2018), 22% of the households in South Korea had a pet in 2016. These factors are expected to drive the market in Asia Pacific during the forecast period.

Pre Book Cat Allergy Therapeutics Market Report- https://www.transparencymarketresearch.com/checkout.php?rep_id=62190&ltype=S

Global Cat Allergy Therapeutics Market: Competitive Landscape

Major players operating in the global cat allergy therapeutics market include Bristol-Myers Squibb Company, GlaxoSmithKline plc, Merck & Co., Inc., Aventis Pharmaceutical, Pharmacia Upjohn, and others. Companies that have cat allergy therapeutic products in pipeline are Sementis and Circassia.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/